DDIT3 and hepatocellular carcinoma: Similar to our study, Fengli Hu et al. also found hepatocellular carcinoma cells with silenced IRE1 expression had a higher viability after treatment with bufalin, whereas cells with silenced CHOP expression did not (Hu et al., 2014).